These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 2239575)
41. [Treatment of prostatic cancer with progestational agents]. Bouffioux C Acta Urol Belg; 1976 Oct; 44(4):336-53. PubMed ID: 1026071 [No Abstract] [Full Text] [Related]
42. Impotence therapy and cancer of the prostate. Guinan PD; Sadoughi W; Alsheik H; Ablin RJ; Alrenga D; Bush IM Am J Surg; 1976 May; 131(5):599-600. PubMed ID: 58562 [TBL] [Abstract][Full Text] [Related]
43. Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer. Fowler JE; Whitmore WF Cancer; 1982 Apr; 49(7):1373-7. PubMed ID: 7059952 [TBL] [Abstract][Full Text] [Related]
44. [Alternative antiandrogen therapy for advanced prostate cancer]. Hiroyoshi S; Endo T; Yano M; Naoi M; Kamiya N Nihon Rinsho; 2011 Jun; 69 Suppl 5():497-501. PubMed ID: 22208032 [No Abstract] [Full Text] [Related]
47. Advanced prostatic cancer revisited--35 years later. Jacobo E; Culp DA J Iowa Med Soc; 1977 Feb; 67(2):52-5. PubMed ID: 839097 [No Abstract] [Full Text] [Related]
48. Perspectives on the clinical management of localized prostate cancer. Nelson JB Asian J Androl; 2014; 16(4):511-4. PubMed ID: 24589461 [TBL] [Abstract][Full Text] [Related]
49. Generalized bleeding following the treatment of prostatic carcinoma with testosterone and radioactive phosphorus. Ellman L J Urol; 1973 Sep; 110(3):331-2. PubMed ID: 4725740 [No Abstract] [Full Text] [Related]
50. Response to tamoxifen in drug-resistant prostatic carcinoma. El-Arini MO Lancet; 1979 Sep; 2(8142):588. PubMed ID: 89595 [No Abstract] [Full Text] [Related]
51. Phase I-II study of high-dose etoposide in patients with refractory breast cancer. Fraschini G; Holmes FA; Esparza L; Theriault RL; Buzdar AU; Hortobagyi GN Invest New Drugs; 1991 Nov; 9(4):365-7. PubMed ID: 1804815 [No Abstract] [Full Text] [Related]
52. [Effectiveness of continuously administered estrogen on the prostatic carcinoma (author's transl)]. Takeuchi H; Yamauchi A Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1552-61. PubMed ID: 745324 [No Abstract] [Full Text] [Related]